Ensuring a secure progesterone supply has become a critical priority for pharmaceutical companies, especially since the pandemic exposed vulnerabilities across the global active pharmaceutical ingredient (API) supply chain. From raw material instability to transport disruptions, progesterone sourcing requires robustness, diversification, and strong industrial partnerships.
This article explains why progesterone is essential, how Safic-Alcan helps secure your progesterone API supply, and how our dual manufacturing processes ensure long-term resilience.
Why Securing a Reliable Progesterone Supply Matters
Progesterone is a key steroid hormone involved in the menstrual cycle, pregnancy, fertility treatment, sleep, weight management, and multiple therapeutic applications. Because of its wide-ranging medical relevance, the global progesterone API market continues to grow sharply.
Applications of progesterone and progestins include:
- contraceptive pills
- hormone replacement therapy (HRT)
- assisted reproductive technologies (ART)
- weight management and metabolic balance
- sleep-related treatments
- veterinary reproduction and heat synchronization
With a CAGR of 14.4% (2020–2025), demand continues rising. However, geopolitical instability, raw material dependence, transportation shortages, and regulatory variability make it harder for pharmaceutical manufacturers to secure uninterrupted progesterone supply.
How Global Supply Chain Instability Affects Progesterone
Since COVID-19, pharma supply chains have faced:
- border closures
- unreliable shipping from China
- container shortages
- export limits on medicines
- fluctuating raw material availability
For these reasons, selecting a partner capable of stabilizing your progesterone API sourcing is now essential.
Two Progesterone Manufacturing Processes: Ensuring Supply Security
At Safic-Alcan, we ensure supply resilience by offering progesterone produced through two independent manufacturing processes, using two different raw materials.
This dual strategy ensures continuity, flexibility, and stability for your long-term pharmaceutical operations.
Process 1: Progesterone from 16-DPA (Diosgenin Route)
The traditional manufacturing method uses 16-dehydropregnenolone acetate (16-DPA) derived from plants.
Advantages
- validated for 30+ years
- CEP obtained in 2003
- 100 MT/year capacity, 500kg batch size
Limitations
- seasonal raw material
- strong dependence on weather
- fluctuating yield and price
- smaller available volumes
The unpredictability of 16-DPA drove the need for a more modern and stable progesterone production route.
Process 2: Progesterone from BA (Bio-Based Route)
The second process uses BA from soy, providing year-round availability with no seasonal impact.
Advantages of BA-based progesterone
- higher and faster yield
- better economic efficiency
- stable pricing
- suitable for multi-year contracts
- improved impurity profile
- customized in-process micronization
- 150 MT/year capacity, 500kg batch size
- CEP expected (2022)
This BA process is the future of securing progesterone API supply, offering consistency and long-term reliability.
Our Manufacturing Partner: Zhejiang Shenzhou Pharmaceutical
Safic-Alcan has been partnered with Zhejiang Shenzhou Pharmaceutical since the 1990s.
Key attributes:
- two manufacturing sites in Eastern China
- 450 employees
- GMP-compliant
- 65% of turnover from exports
- specialized in steroid APIs for 30+ years
A brand-new factory built in Xianju county meets environmental and Chinese regulatory requirements. It includes two dedicated progesterone workshops (one per process) and in-house waste treatment facilities—ensuring supply continuity with no relocation risk.
Safic-Alcan & Shenzhou: A 20-Year Strategic Partnership
Our long-term collaboration strengthens your ability to secure progesterone API supply through:
Regulatory & Quality Advantages
- first progesterone CEP produced in China (2001) initiated by Safic-Alcan
- product registered in MA dossiers in 70+ countries
- EDQM inspection (2007) triggered by Safic-Alcan
- QARA support for all CEP, DMF, and client submissions
- alignment with EP monographs (EP 8.3)
Business & Supply Chain Advantages
- customizable specifications (particle size, impurity profile)
- globalized volumes for better pricing
- turnkey delivery directly to your factory
- safety stock availability in France
- fast issue resolution thanks to our China-based Safic-Alcan team
This combined technical, regulatory, and cultural proximity makes Safic-Alcan one of the strongest progesterone distributors in the pharmaceutical sector.
Be Part of the Future of Progesterone Supply
With our dual manufacturing routes, advanced regulatory expertise, and 20-year partnership with Shenzhou, Safic-Alcan is positioned to help you secure your progesterone supply for the next decade. As the BA process expands and regulatory approvals progress, availability and cost stability will continue improving.
For reliable, cost-effective, and future-proof progesterone sourcing, contact us today.